https://irancohorts.ir/wp-content/uploads/2021/12/Diabetes-Metab-Syndr.jpg259194IDPChttps://irancohorts.ir/wp-content/uploads/2021/09/IranCohorts-1.pngIDPC2016-03-03 08:56:302022-01-03 09:03:53Risk of diabetes in combined metabolic abnormalities and body mass index categories
https://irancohorts.ir/wp-content/uploads/2016/01/Rev-Diabet-Stud.jpg227173IDPChttps://irancohorts.ir/wp-content/uploads/2021/09/IranCohorts-1.pngIDPC2016-01-29 07:42:022022-01-13 07:59:43Low Levels of High-Density Lipoprotein Cholesterol Do Not Predict the Incidence of Type 2 Diabetes in an Iranian High-Risk Population: The Isfahan Diabetes Prevention Study
https://irancohorts.ir/wp-content/uploads/2016/11/4.jpg204159IDPChttps://irancohorts.ir/wp-content/uploads/2021/09/IranCohorts-1.pngIDPC2015-11-30 12:56:562022-01-12 13:04:42Efficacy of bromocriptine on glycemic and metabolic control of prediabetic patients
https://irancohorts.ir/wp-content/uploads/2021/08/36-Determinants-of-Weight-Changejpg_Page1.jpg1056816ICShttps://irancohorts.ir/wp-content/uploads/2021/09/IranCohorts-1.pngICS2015-09-10 06:23:332021-11-20 09:49:29Determinants of Incident Prediabetes and Type 2 Diabetes in a 7-year Cohort in a Developing Country: The Isfahan Cohort Study
https://irancohorts.ir/wp-content/uploads/2022/01/Hypertens-Res.png589440IDPChttps://irancohorts.ir/wp-content/uploads/2021/09/IranCohorts-1.pngIDPC2015-02-19 10:34:072022-01-01 10:43:00Glucose and the risk of hypertension in first-degree relatives of patients with type 2 diabetes
https://irancohorts.ir/wp-content/uploads/2021/12/Rev-Diabet-Stud.gif75500IDPChttps://irancohorts.ir/wp-content/uploads/2021/09/IranCohorts-1.pngIDPC2014-02-10 13:02:482021-12-29 13:09:38Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome
https://irancohorts.ir/wp-content/uploads/2022/01/J-Diabetes-Metab-Disord.jpg183138IDPChttps://irancohorts.ir/wp-content/uploads/2021/09/IranCohorts-1.pngIDPC2014-02-04 12:46:532022-01-12 12:53:21Executive functions and information processing in patients with type 2 diabetes in comparison to pre-diabetic patients
https://irancohorts.ir/wp-content/uploads/2021/08/42-Anthropometric-indices-predicting-incident-type-2-diabetes-in-an-Iranian-populationjpg_Page1.jpg1059793ICShttps://irancohorts.ir/wp-content/uploads/2021/09/IranCohorts-1.pngICS2013-10-09 08:04:362021-11-21 06:33:48Anthropometric indices predicting incident type 2 diabetes in an Iranian population: The Isfahan Cohort Study
https://irancohorts.ir/wp-content/uploads/2012/10/2.png190148IDPChttps://irancohorts.ir/wp-content/uploads/2021/09/IranCohorts-1.pngIDPC2012-11-02 05:28:232022-01-13 07:11:28Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes?
https://irancohorts.ir/wp-content/uploads/2022/01/ISRN-Endocrinol.gif75500IDPChttps://irancohorts.ir/wp-content/uploads/2021/09/IranCohorts-1.pngIDPC2012-10-16 04:54:412022-01-03 05:20:49Patterns and predictors of long-term glycemic control in patients with type 2 diabetes
